This analysis uses data from several sources, including two Center surveys conducted in 2024 and 2025
This weight loss injection is not prescribed to patients with certain conditions, such as type 1 or type 2 diabetes, diabetic ketoacidosis, chronic kidney disease, pancreatitis, a personal or family history of medullary thyroid carcinoma, or a history of multiple endocrine neoplasia type 2
The most widely known GLP-1 medications include semaglutide and tirzepatide, sold under brand names such as Wegovy, Ozempic, and Mounjaro
Your journey is unique, and were here to support you every step of the way
Our medical weightloss program uses tirzepatide when appropriatepaired with nutrition, movement, and behavior coachingto help eligible adults lose weight safely and sustainably